Post #1651217

@hildabast The Stanford TLR4 agonists/ovalbumin looks incredibly interesting and exciting for limited short-term use, but I worry that causing low-level inflammation long-term would increase the risk of heart disease, diabetes, and cancer. 😠 The Colombia paper on *their* universal vaccine (https://www.science.org/doi/10.1126/scitranslmed.adx5758 ) said that some people who never get sick are missing the ISG15 gene, which gives them low-level inflammation. I know someone who never got sick, and they had *four* totally different cancers before they died. I wonder if they were missing ISG15.